Phase II Study of Ganitumab, a Fully Human Anti-Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors.
| Autor: | Tap WD, Demetri G, Barnette P, Desai J, Kavan P, Tozer R, Benedetto PW, Friberg G, Deng H, McCaffery I, Leitch I, Badola S, Chang S, Zhu M, Tolcher A |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 5/20/2012, Vol. 30 Issue 15, p1849-1856, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|